News Pfizer finally decides not to split up company Company will remain as one, but Read keeps his options open
News Unjustified price rises will stop, promises Allergan chief Says 'outlier' companies have 'violated' social contract
Views & Analysis The biggest pharma stories of 2016 so far The top 10 pharma milestones of the year to date.
Oncology CAR-T therapies: Faster, better, cheaper In a new pharmaphorum podcast, editor-in-chief Jonah Comstock speaks with Phil Johnson, MD, president and CEO of Interius Biotherapeutics.
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
